Predictors of Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Results From the Surveillance, Epidemiology and End Results Program 2003 Patterns of Care Project-Reference-Cited by-同舟云学术

Predictors of Intravesical Therapy for Nonmuscle Invasive Bladder Cancer: Results From the Surveillance, Epidemiology and End Results Program 2003 Patterns of Care Project

Published:2008-08 Issue:2 Volume:180 Page:520-524
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Huang George J.¹,Hamilton Ann S.²,Lo Mary²,Stein John P.¹,Penson David F.¹²

Affiliation:

1. Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California

2. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Explaining black-white differences in receipt of recommended colon cancer treatment;Baldwin;J Natl Cancer Inst,2005

2. Race, socioeconomic status, and breast cancer treatment and survival;Bradley;J Natl Cancer Inst,2002

3. Geographic and socioeconomic variation in the treatment of prostate cancer;Krupski;J Clin Oncol,2005

4. Variations in prostate cancer patterns of care: is it the quality of care or the quality of the data?;Penson;J Clin Oncol,2005

5. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer;Hodgson;J Natl Cancer Inst,2001

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006–2018: Effect of race, age and socioeconomic status on treatment disparities;Urologic Oncology: Seminars and Original Investigations;2023-10

2. Quality Control Indicators for Transurethral Resection of Bladder Tumor: Results from an Embedded Belgian Multicenter Prospective Registry;European Urology Oncology;2022-12

3. Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2022-11

4. Knowledge of and Compliance With Guidelines in the Management of Non-Muscle-Invasive Bladder Cancer: A Survey of Chinese Urologists;Frontiers in Oncology;2021-10-27

5. Increased Bacillus Calmette-Guérin Treatment Intensity Associated With Improved Outcomes in Elderly Patients With Non–Muscle-invasive Bladder Cancer in United States Clinical Practice;Urology;2020-11